Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gstettner Christian |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Pernthaler, B; Kvaternik, H; Kulnik, R; Gstettner, C; Aigner, RM Prospective intra-patient comparison of 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT in biochemical recurrence of prostate cancer after definitive therapy
Eur J Nucl Med Mol Imaging (2019) 46 (Suppl 1): S1–S952. 2019; 46: 24-24.-EANM 2019, Annual Congress of the European Association of Nuclear Medicine; October 12 – 16, 2019; Barcelona, SPAIN. [Oral Communication]
FullText

 

Pernthaler, B; Kvaternik, H; Kulnik, R; Gstettner, C; Aigner, RM Prospective intra-patient comparison of F-18-Fluciclovine and Ga-68-PSMA-11 PET/CT in biochemical recurrence of prostate cancer after definitive therapy
EUR J NUCL MED MOL I. 2019; 46(SUPPL 1):S24-S24.-32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 12-16, 2019; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Pernthaler, B; Nazerani Hooshmand, T; Gstettner, C; Herzog, SA; Aigner, RM Metabolic tumor parameters in F18-FDG PET/CT as a reliable predictor on overall survival in patients with cervical carcinoma
EUR J NUCL MED MOL I. European Journal of Nuclear Medicine and Molecular Imaging (2019) 46 (Suppl 1): S1–S952. 2019; 46(SUPPL 1):S550-S551.-32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 12-16, 2019; Barcelona, SPAIN. [Poster]
Web of Science FullText

 

Trummer, C; Reiher, H; Theiler-Schwetz, V; Pandis, M; Gstettner, C; Obermayer-Pietsch, B; Stepan, V; Pilz, S Ektopes TSH-produzierendes Hypophysenadenom: Ein Fallbericht
24. ÖGES Jahrestagung 2019, gemeinsam mit OSDG & ANETS; APR 24-26, 2019; Graz, AUSTRIA. 2019. [Poster]

 

Pernthaler, B; Herzog, SA; Kulnik, R; Gstettner, C; Aigner, RM F18-FDG PET/CT bei PatientInnen mit Ösophaguskarzinom: prognostische Wertigkeit.
Nuklearmedizin. 2018; 57(02):A62--56. Jahrestagung Der Deutschen Gesellschaft Für Nuklearmedizin; April 18-21, 2018; Bremen, GERMANY. [Poster]

 

Pernthaler, B; Kulnik, R; Gstettner, C; Herzog, SA; Aigner, RM Pretreatment metabolic parameter in F18-FDG PET/CT predict overall survival in squamous cell esophageal cancer
EUR J NUCL MED MOL I. 2018; 45: S493-S493.-31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 13-17, 2018; Dusseldorf, GERMANY. [Poster]
Web of Science

 

Martin Eibisberger, Johannes Schmid, Horst Portugaller, Christian Gstettner, Roman Kulnik, Michael Sacherer, Carmen Salvan-Schaschl Case report: Primary angiosarcoma of the right atrium in a 33 years old athelete (Prezentare de caz: angiosarcom primar al atriului drept la un sportiv de 33 ani)
www.srim.ro. 2017; 29-30.-Congresul National de Radiologie si Imagistica Medicala; Oct 5-8, 2017; Bucuresti, Romania. [Keynote lecture]

 

Pernthaler, B; Hirsch, T; Herzog, SA; Stanzel, S; Gstettner, C; Aigner, RM Korrelation der metabolischen Tumorparameter im F18- FDG PET/CT und dem Overall Survival beim kleinzelligen Bronchialkarzinom
Nuklearmedizin Kongressausgabe 55. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin Dresden 2017. 2017; 56 (2):A2-A91.-55. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin; APR 26-29, 2017; Dresden, GERMANY. [Oral Communication]
FullText

 

Pernthaler,B Andjelic, A; Gstettner, C; Schwarz,T Vom Erythem zum Glukagonom: Paraneoplastisches Erythema necroticans migrans und Ga68 DOTA-NOC wegweisend für Primärdiagnostik eines Glukagonoms
ANETS Jahrestagung 2016; SEP 23,2016; Salzburg, Österreich. 2016. [Poster]

 

Kerschbaumer, S; Hofbauer, L; Kvaternik, H; Gstettner, C; Aigner, RM Comparison of time-of-flight PET-CT results for micro hollow spheres from 31 microliter to 8 milliliter for Fluorine-18, Gallium-68 and Yttrium-90.
EUR J NUCL MED MOL I. 2015; 42: S341-S341.-28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 10-14, 2015; Hamburg, GERMANY. [Poster]
Web of Science

 

Kulnik, R; Pernthaler, B; Herzog, SA; Gstettner,C; Aigner, RM F18-FDG PET/CT: Wertigkeit von Atemtriggerung und TOF zur Dignitätsbeurteilung von Lungenläsionen.
Nuklearmedizin . 2015; 54(2):53-74.-53. DGN-Jahrestagung in Hannover 2015; April 22-25, 2015; Hannover, Deutschland. [Oral Communication]
FullText

 

Gstettner, C; Reinbacher, KE; Kerschbaumer, S; Aigner, R Clinical impact of 18F-FDG PET-CT in orbital tumors
EUR J NUCL MED MOL I. 2014; 41: S525-S525.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 18-22, 2014; Gothenburg, SWEDEN. [Poster]
Web of Science

 

Kerschbaumer, S; Stücklschweiger; H, Kvaternik, H; Gstettner, C; Guss, H; Aigner, RM. Routine estimation of effective patient dose for SPECT-CT and PET-CT hybride cameras in nuclear medicine diagnostic.
Dreiländertagung der Medizinischen Physik; SEP 7-10, 2014; Zürich, Schweiz. 2014. [Poster]

 

Kulnik, R; Gstettner, C; Heber, D; Aigner, R Is there an increased incidence of dental infections in patients with prosthesis infection?
Nuklearmedizin/Nuclear Medicine, Molecular Imaging and Therapy, Kongressausgabe. 2014; 2013(52):205-257.-31st Symposium, Radioactive Isotopes in Molecular Imaging; JÄN 22-25, 2014; Zell am See, Austria. [Poster]

 

Gstettner, C; Kerschbaumer, S; Aigner, R Clinical impact of increased oral F-18- FDG tracer-uptake in follow up of oral squamous cell carcinoma
EUR J NUCL MED MOL I. 2013; 40: S250-S250.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 19-23, 2013; Lyon, FRANCE. [Oral Communication]
Web of Science

 

Gstettner, C; Kerschbaumer, S; Heber, D; Aigner, R Suspicious single rip lesions in planar bone szintigraphy- Can SPECT-CT clarify the results?
EUR J NUCL MED MOL I. 2013; 40: S390-S390.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 19-23, 2013; Lyon, FRANCE. [Poster]
Web of Science

 

Gstettner, C; Kerschbaumer, S; Kofer, K; Heber, D; Aigner, R Correlation of total lesion glycolysis (TLG) and tumor marker in liver metastases in the follow up of colon rectal cancer.
EUR J NUCL MED MOL I. 2013; 40: S364-S364.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 19-23, 2013; Lyon, FRANCE. [Poster]
Web of Science

 

Kerschbaumer, S; Gstettner, C; Triebl, A; Schrottner, B; Aigner, R How to gain comparable low-dose protocols for different hybrid and stand-alone CT-scanners based on image-noise measurement-results - using a Tissue-Characterization-Phantom and an Alderson-Phantom
EUR J NUCL MED MOL I. 2013; 40: S186-S186.-Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 19-23, 2013; Lyon, FRANCE. [Oral Communication]
Web of Science

 

Kulnik, R; Gstettner, C; Köfer, K; Heber, D; Beham-Schmid, C; Aigner, R; Korrelation zwischen Prozentsatz der Plasmalzellinfiltration im Beckenkamm und SUV im F18-FDG-PET-CT
Nuklearmedizin Kongressausgabe. 2013; 2012(51):213-256.-10. Nationaler Kongress der Österreichischen Gesellschaft für Nuklearmedizin und Molekulare Bildgebung; JAN 16-18, 2013; Zell am See, AUSTRIA. [Oral Communication]

 

Gstettner, C; Köfer, K; Kerschbaumer, S; Heber, D; Triebl, A; Aigner, R Clinical impact of 99m Tc DPD 3D-SPECT-CT in single suspicious metastatic bone lesions
EANM 2012; OKT 27-31, 2012; Milano, ITALY. 2012. [Poster]

 

Gstettner, C; Köfer, K; Kerschbaumer, S; Heber, D; Triebl, A; Aigner, R Vorteil eines zusätzlichen SPECT-CT-Protokolls bei verdächtigen solitären Knochenläsionen als Erweiterung der 99m Tc DPD Untersuchung
OERG 2012; SEP 13-15, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

 

Gstettner, C; Kofer, K; Kerschbaumer, S; Heber, D; Triebl, A; Aigner, R; Clinical impact of (99m) Tc DPD 3D-SPECT-CT in single suspicious metastatic bone lesions.
EUR J NUCL MED MOL IMAGING. 2012; 39: S492-S492.-25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 27-31, 2012; Milan, ITALY. [Poster]
Web of Science

 

Jakse, G; Gstettner, C; Langsenlehner, T; Partl, R; Reinisch, S; Kapp, KS Influence of SUV and complete metabolic Remission on local Tumor control after combined Radiochemotherapy of advanced ENT tumors.
Strahlentherapie und Onkologie. 2012; 188(1):185-186.-28. ÖGRO-Jahrestagung 2011; NOV 17-19, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Kerschbaumer, S; Gstettner, C; Aigner, R; Evaluation of the clinical impact of Time-OF-Flight (TOF) PET/CT-scans for F18-FDG whole body protocol on a Siemens Biograph mCT.
EUR J NUCL MED MOL IMAGING. 2012; 39: S386-S386.-25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 27-31, 2012; Milan, ITALY. [Poster]
Web of Science

 

Kerschbaumer, S; Gstettner, C; Lipp, R; Aigner, R; A phantom study of gamma-probe-based freehand functional imaging for stereotactic navigated interventions.
EUR J NUCL MED MOL IMAGING. 2012; 39: S509-S509.-25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM); OCT 27-31, 2012; Milan, ITALY. [Poster]
Web of Science

 

Kerschbaumer, S; Bernhardt, GA; Gstettner, C; Mischinger, HJ; Aigner RM; A new approach using standardized parameters for the quantitative evaluation of hepatobiliary scintigraphy: the first results
Interactive Programme Planner of the EANM '11. 2011; -EANM '11; Annual Congress of the European Association of Nuclear Medicine; OCT 15-19, 2011; Birmingham, UK. [Poster]
FullText

 

Bisail, B; Bisail, H; Gstettner, C; Wolf, I; Aigner, RM Radiological Guidelines for the Management of SPN:Necessity of F18-FDG.
Nuclear Medicine - Molecular Imaging and Therapy 2009; 6/08(47):A153-A153.-7.Jahrestagung der Österreichischen Gesellschaft für Nuklearmedizin; Jan 22-24, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Gstettner, C Ösophaguskarzinom
Fortbildungsabend der Universitätsklinik für Radiologie, Schwerpunkt Onkologie; 17.11.2009; Graz, Austria. 2009. [Oral Communication]

 

Gstettner, C; Bisail, B; Wolf, I; Passath, A; Aigner, RM Plattenepithelkarzinom des Ösophagus:Diagnostische Wertigkeit von F18-FDG PET/CT an lokoregionären Lymphknoten.
Nuclear Medicine - Molecular Imaging and Therapy2009; 6/08(47):A158-A159.-7.Jahrestagung der Österreichischen Gesellschaft für Nuklearmedizin; Jan 22-24, 2009; Salzburg, AUSTRIA. [Poster]

 

Gstettner, C; Ehammer, T; Mohamad Al-Ali, B; Aigner, RM Case report: Detection of an unexpected prostate cancer single clavicular bone metastasis with F18-cholin
Abstracts Book. 2009; -VII.Urological Alpe Adria Meeting; 17.10.2009; Klagenfurt/Austria. [Oral Communication]

 

Gstettner, C; Stanzel, S; Feichtinger, M; Aigner, RM Is the application of F18-FDG PET-CT in carcinoma of the lip justified?
Nuklearmedizin. 2009; 48(6):A156-A156.-29. Internationale Symposium der Österreichischen Gesellschaft für Nuklearmedizin (ÖGN)-Radioactive Isotopes in Clinical Medicine and Research; JAN 16-19, 2010; Bad Hofgastein, AUSTRIA. [Oral Communication]
FullText

 

Stanzel, S; Schwarz, T; Gstettner, C; Aigner, R Comparison of myocard-gated-SPECT-findings in females and males with essential arterial hypertension
Nuklearmedizin. 2009; 48(6):A160-A160.-29. Internationale Symposium der Österreichischen Gesellschaft für Nuklearmedizin (ÖGN) - Radioactive Isotopes in Clinical Medicine and Research; Jan 16-19, 2010; Bad Hofgastein, AUSTRIA. [Poster]
FullText

 

Gstettner, C Vorstellung der Nuklearmedizinischen Abteilung
; 27.Oktober 2008; LKH Bad Aussee. 2008. [Keynote lecture]

 

Gstettner, C Suspekter Krampfanfall.
; 30.10.2008; Graz, Austria. 2008. [Oral Communication]

 

Gstettner, C 8er Neuroimaging Workshop Nuklearmedizin- Kognition und Bewegungsstörung Fallbeispiel Morbus Parkinson
; Juli 2008; 2008. [Oral Communication]

 

Gstettner, C PEt-CT-weltweiter Weg zum Erfolg Ösophaguskarzinom
11. Wissenschaftliche Sitzung der wissenschftlichen Gesellschaft der Ärzte in der Steiermark; MAi,08,2008; Graz, Austria. 2008. [Oral Communication]

 

Gstettner, C Role of F18 FDG PET CT after radiofrequenzablation of liver metastases
; 22.Oktober 2008; Univeristätsklinik für Radiologie Graz, Bibliothek. 2008. [Oral Communication]

 

Gstettner, C; Reingard.M.Aigner FDG PET beim Melanom
; Nov 21, 2008; Graz, Austria. 2008. [Oral Communication]

 

© Med Uni Graz Impressum